Skip to main content

MARSHALL WACE, LLP

Position in IMCR — Immunocore Holdings plc

CIK 1318757 LONDON, X0

Position in IMCR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,437,251
+$3,314,285 QoQ
Shares Held
180,340
+194.9% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in IMCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,764,425,276 across 279 Biotechnology names. IMCR ranks #93 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMCR

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,437,251 180,340
2025-12-31 $2,122,966 61,163
2025-09-30 $4,477,381 123,242
2025-06-30 $4,600,621 146,610
2025-03-31 $827,258 27,882
2024-12-31 $843,994 28,610
2024-09-30 $6,208,659 199,443
2024-06-30 $8,426,883 248,654
2024-03-31 $14,166,815 217,951
2023-09-30 $4,444,664 85,639
2023-06-30 $5,324,687 88,804
2023-03-31 $1,192,492 24,120
2022-12-31 $1,733,786 30,380
2022-09-30 $1,132,192 24,120
2022-06-30 $899,917 24,120
2022-03-31 $721,188 24,120
2021-12-31 $825,868 24,120